Apricus Biosciences (APRI) Misses Q3 EPS by 13c
Tweet
Share
E-mailGet Alerts APRI Hot Sheet
Join SI Premium – FREE
Apricus Biosciences (NASDAQ: APRI) reported Q3 EPS of ($0.29), $0.13 worse than the analyst estimate of ($0.16).
For earnings history and earnings-related data on Apricus Biosciences (APRI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna Group plc (KLAR) Tops Q2 EPS by 6c, Beats on Revenue; Offers FY26 Revenue Guidance
- iQIYI (IQ) Misses Q2 EPS by 21c
- VNET Group (VNET) Misses Q2 EPS by 164c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
